Check out Figure 6 in this paper: https://royalsocietypublishing.org/doi/full/10.1098/rsif.2014.0873 https://royalsocietypublishing.org/doi/full/10.1098/rsif.20

Check out Figure 6 in this paper: https://royalsocietypublishing.org/doi/full/10.1098/rsif.2014.0873 https://royalsocietypublishing.org/doi/full/10.1098/rsif.201... "we ... compare resting-state functional brain activity in 15 healthy volunteers after intravenous infusion of placebo and psilocybin—the main psychoactive component of magic mushrooms. The results show that the homological structure of the brain's functional patterns undergoes a dramatic change post-psilocybin, characterized by the appearance of many transient structures of low stability and of a small number of persistent ones that are not observed in the case of placebo." Psilocybin promotes neuroplasticity/neurogenesis, and the effect isn't subtle. Yet its application is still on the fringe. It's not surprising that this makes a financier salivate. It's more surprising that it isn't yet a gold rush.